Sale!

FGFR1 Gene Kallmann Syndrome Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FGFR1 Gene Kallmann Syndrome Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the FGFR1 gene that are associated with Kallmann Syndrome Type 2. Kallmann Syndrome is a genetic condition characterized by delayed or absent puberty and an impaired sense of smell, resulting from a combination of hormonal and neurological anomalies. The FGFR1 gene plays a crucial role in the development of the olfactory system and the hypothalamic area of the brain, which are integral to the sense of smell and the regulation of reproductive hormones.

This genetic test is pivotal for individuals showing symptoms of Kallmann Syndrome or those with a family history of the condition, as it provides a definitive diagnosis by identifying mutations in the FGFR1 gene. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to look for genetic alterations.

Offered at a cost of 4400 AED, the FGFR1 Gene Kallmann Syndrome Type 2 Genetic Test at DNA Labs UAE is a crucial step towards personalized treatment and management plans for affected individuals. It not only helps in confirming the diagnosis but also aids in understanding the risk of passing the condition to future generations, thereby facilitating informed family planning decisions.

Description

FGFR1 Gene Kallmann Syndrome Type 2 Genetic Test

Test Name: FGFR1 Gene Kallmann Syndrome Type 2 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Hepatology Nephrology Endocrinology Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for FGFR1 Gene Kallmann Syndrome Type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR1 Gene Kallmann Syndrome Type 2 NGS Genetic DNA Test gene FGFR1.

Test Details:

The FGFR1 gene is associated with Kallmann syndrome type 2, a rare genetic disorder characterized by delayed or absent puberty and an impaired sense of smell (anosmia or hyposmia). Kallmann syndrome type 2 is caused by mutations in the FGFR1 gene, which is responsible for encoding a protein involved in the development and functioning of the hypothalamus and olfactory system.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and detect genetic variations, including mutations, in an individual’s DNA. In the context of Kallmann syndrome type 2, NGS genetic testing can be used to identify specific mutations in the FGFR1 gene that may be responsible for the disorder.

By analyzing the DNA sequence of the FGFR1 gene, NGS genetic testing can provide a definitive diagnosis of Kallmann syndrome type 2. This information can be crucial for appropriate medical management, genetic counseling, and family planning.

It is important to note that NGS genetic testing for Kallmann syndrome type 2 may require a healthcare provider’s prescription and should be performed by a qualified laboratory specializing in genetic testing. Genetic counseling is also recommended before and after testing to discuss the potential implications of the results and any further actions that may be necessary.

Test Name	FGFR1 Gene Kallmann syndrome type 2 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Hepatology Nephrology Endocrinology Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for FGFR1 Gene Kallmann syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR1 Gene Kallmann syndrome type 2 NGS Genetic DNA Test gene FGFR1
Test Details	The FGFR1 gene is associated with Kallmann syndrome type 2, a rare genetic disorder characterized by delayed or absent puberty and an impaired sense of smell (anosmia or hyposmia). Kallmann syndrome type 2 is caused by mutations in the FGFR1 gene, which is responsible for encoding a protein involved in the development and functioning of the hypothalamus and olfactory system. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and detect genetic variations, including mutations, in an individual’s DNA. In the context of Kallmann syndrome type 2, NGS genetic testing can be used to identify specific mutations in the FGFR1 gene that may be responsible for the disorder. By analyzing the DNA sequence of the FGFR1 gene, NGS genetic testing can provide a definitive diagnosis of Kallmann syndrome type 2. This information can be crucial for appropriate medical management, genetic counseling, and family planning. It is important to note that NGS genetic testing for Kallmann syndrome type 2 may require a healthcare provider’s prescription and should be performed by a qualified laboratory specializing in genetic testing. Genetic counseling is also recommended before and after testing to discuss the potential implications of the results and any further actions that may be necessary.